Advertisement
Advertisement

TLPH

TLPH logo

Talphera Inc.

0.6251
USD
-0.0049
-0.78%
Dec 18, 15:25 UTC -5
Closed
...

Talphera Inc. Profile

About

Talphera Inc. is a specialty pharmaceutical company. It focused on the development and commercialization of therapies for use in medically supervised settings. The company's lead product candidate consists Niyad(TM). Talphera Inc., formerly known as AcelRx Pharmaceuticals Inc., is based in SAN MATEO, Calif.

Info & Links

CEO

Vincent J. Angotti

Headquarters

1850 Gateway Drive, Suite 175
San Mateo, CA 94404, UNITED STATES

Auditor

BPM LLP

Share holders

46

Employees

15

Talphera Inc. Statistics

Valuation Measures

Market Capitalization2

10.65M

Enterprise Value

-471.55K

Enterprise Value/EBITDA(ttm)

0.03

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

1.15

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

25.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

-401.87%

Return on Equity(ttm)

-118.46%

Return on Invested Capital(ttm)

-120.99%

Return on Assets(ttm)

-65.82%

Income Statement

Revenue(ttm)

281.00K

Revenue Per Share(ttm)

0.02

Gross Profit(ttm)

281.00K

EBITDA(ttm)3

-16.52M

Net Income Available to Common(ttm)

-15.65M

Diluted EPS(ttm)

-0.69

Share Statistics

Beta (5Y Monthly)

0.25

52-Week Change

-24.69%

S&P 500 52-Week Change

23.87%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

17.03M

Dividend Yield

0.00%

Float4

16.48M

% Held by Insiders

3.20%

% Held by Institutions

37.67%

Balance Sheet

Total Cash(mrq)

11.12M

Total Cash Per Share(mrq)

0.65

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

4.42%

Quick Ratio(mrq)

4.42%

Book Value Per Share(mrq)

0.57

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.40

Free Cash Flow(ytd)

-10.43M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement